AEON (AEON Biopharma) FCF Margin %: 0.00% (As of Mar. 2026)


AEON AEON Biopharma Inc AEON
10 GF Score
Price $0.72
! 2 Warning Signs
View Full Analysis

What is AEON Biopharma FCF Margin %?

AEON Biopharma AEON +4.62% 10 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates AEON with a GF Score™ of 10/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, AEON Biopharma ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AEON Biopharma's Free Cash Flow for the three months ended in Mar. 2026 was $-2.64 Mil. AEON Biopharma's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, AEON Biopharma's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, AEON Biopharma's current FCF Yield % is -63.36%.

The historical rank and industry rank for AEON Biopharma's FCF Margin % or its related term are showing as below:


During the past 7 years, the highest FCF Margin % of AEON Biopharma was -375.73%. The lowest was -1382.75%. And the median was -879.24%.

AEON's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

AEON Biopharma FCF Margin % Related Terms

AEON Biopharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for AEON Biopharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AEON Biopharma FCF Margin % Chart

AEON Biopharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

AEON Biopharma Quarterly Data
Dec19 Dec20 Jun21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AEON vs GRTX, XCUR, ANEB: FCF Margin % Comparison

For the Biotechnology subindustry, AEON Biopharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AEON Biopharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AEON Biopharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where AEON Biopharma's FCF Margin % falls into.


AEON
10GF Score
AEON Biopharma Inc AEON
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AEON Biopharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

AEON Biopharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-17.312/0
= %

AEON Biopharma's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.636/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
AEON Biopharma (AEON) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AEON Biopharma and its competitors. According to the industry distribution chart, AEON Biopharma ranks #999999 out of 959 companies in the Biotechnology industry.
Is AEON Biopharma's FCF Margin % too high?
AEON Biopharma's current FCF Margin % is 0.00%. Based on the distribution chart, AEON Biopharma ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, AEON Biopharma has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does AEON Biopharma's FCF Margin % compare to GRTX and XCUR?
According to the Biotechnology industry distribution chart, AEON Biopharma ranks #999999 out of 959 companies for FCF Margin %. This places AEON Biopharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AEON Biopharma and its competitors. AEON Biopharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AEON Biopharma stock overvalued right now?
AEON Biopharma (AEON) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. AEON Biopharma's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For AEON Biopharma (AEON), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AEON Biopharma Business Description

Address 5 Park Plaza, Suite 1750, Irvine, CA, USA, 92614
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
10GF Score

Get the complete analysis for AEON

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.72
Price